Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21300527 | 0.87 | POLB (0.37) | LMNAPOLBSMN1; SMN2PPARG | |
| SCHEMBL39056 | 0.87 | POLB (0.37) | LMNAPOLBSMN1; SMN2PPARG | |
| Diclofop-Methyl SCHEMBL7587664 | 0.83 | FFAR1 (0.34) | HTTPOLBSMN1; SMN2PPARGP2RX3 | |
| SCHEMBL5467634 | 0.83 | L3MBTL1 (0.39) | MAPTLMNAPOLBSMN1; SMN2PPARG | |
| Clopyralid SCHEMBL7580470 | 0.82 | PPARG (0.35) | MAPTPOLBSMN1; SMN2PPARGP2RX3 | |
| Dimethachlor SCHEMBL7586027 | 0.80 | POLB (0.31) | POLBSMN1; SMN2 | |
| SCHEMBL7836459 | 0.80 | SMN1; SMN2 (0.36) | MAPTLMNAPOLBSMN1; SMN2 | |
| SCHEMBL4829878 | 0.80 | PPARG (0.40) | PPARG | |
| SCHEMBL4829867 | 0.80 | PPARG (0.40) | PPARG | |
| Terbuthylazine SCHEMBL7580710 | 0.80 | GAA (0.33) | POLBSMN1; SMN2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | MAPT 1092/4885LMNA 3881/4885CYP1A2 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.